Rate My Professor Dana LeVine

Dana N. LeVine is an Associate Professor of Small Animal Internal Medicine in the Department of Clinical Sciences at Auburn University College of Veterinary Medicine, a position she has held since 2021. She earned her DVM from Cornell University College of Veterinary Medicine in 2004, followed by a rotating internship in small animal medicine and surgery at the University of Georgia. From 2005 to 2013, LeVine completed a clinician investigator program at North Carolina State University College of Veterinary Medicine, which included a small animal internal medicine residency and culminated in a PhD in Comparative Biomedical Sciences focused on developing a comparative canine model of immune thrombocytopenia (ITP). She became board-certified by the American College of Veterinary Internal Medicine in Small Animal Internal Medicine in 2009. Prior to joining Auburn, LeVine served on the faculty at Iowa State University College of Veterinary Medicine from 2013 to 2021.

LeVine's research centers on immune-mediated hematological disorders, particularly immune-mediated hemolytic anemia (IMHA) and ITP in dogs. Her laboratory investigates thromboembolism in IMHA, emphasizing the role of neutrophil extracellular traps (NETs). She was the first to demonstrate that canine neutrophils generate NETs, which activate canine platelets, accelerate plasma clot formation, and impair clot lysis. Her work has established elevated NET markers in dogs with IMHA and is advancing NETosis assays and regulation studies, positioning NETs as potential therapeutic targets. LeVine also explores the immunologic and genetic pathogenesis of ITP to develop targeted therapies. Key publications include the ACVIM consensus statements on the diagnosis (2024) and treatment (2024) of immune thrombocytopenia in dogs and cats, "Immune thrombocytopenia (ITP): Pathophysiology update and diagnostic dilemmas" (Veterinary Clinical Pathology, 2019), and "Characterization of post-transfusion anti-FEA 1 alloantibodies in transfusion-naive FEA 1-negative cats" (Journal of Feline Medicine and Surgery, 2022). She serves as President of the Association of Veterinary Hematology and Transfusion Medicine and Secretary of the Veterinary and Comparative Clinical Immunology Association, contributing to advancements in veterinary hematology, transfusion medicine, and immunology.